Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Evolus (EOLS) Shares Outstanding (2017 - 2026)

Evolus filings provide 10 years of Shares Outstanding readings, the most recent being $65.8 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 2.16% to $65.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $65.8 million, a 2.16% increase, with the full-year FY2025 number at $65.0 million, up 2.38% from a year prior.
  • Shares Outstanding hit $65.8 million in Q1 2026 for Evolus, up from $65.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $65.8 million in Q1 2026 to a low of $56.0 million in Q1 2022.
  • Median Shares Outstanding over the past 5 years was $62.3 million (2024), compared with a mean of $60.6 million.
  • The widest YoY moves for Shares Outstanding: up 28.13% in 2022, down 1.13% in 2022.
  • Evolus' Shares Outstanding stood at $56.3 million in 2022, then increased by 2.77% to $57.8 million in 2023, then rose by 9.82% to $63.5 million in 2024, then rose by 2.38% to $65.0 million in 2025, then rose by 1.28% to $65.8 million in 2026.
  • The last three reported values for Shares Outstanding were $65.8 million (Q1 2026), $65.0 million (Q4 2025), and $64.8 million (Q3 2025) per Business Quant data.